New Release: Alpha testing version has been released.

Dydrogesterone

G03D - Progestogens ATC G03DB01 Small molecule approved 1982 Oral Natural product

JFDA label: Duphaston Tab

Mechanism of Action

Agonist of Progesterone receptor — Progesterone receptor agonist

TargetActionGene / class
Progesterone receptor efficacy AGONIST PGR

Indications

Off-label

  • Abortion, Habitual
  • Infertility
  • Infertility, Female
  • Menopause
  • Pregnancy
  • Premature Birth

Pregnancy & Lactation

Pregnancy

Chemistry & Properties

2D structure
FormulaC21H28O2
Molecular weight312.45 g/mol
IUPAC name(8S,9R,10S,13S,14S,17S)-17-acetyl-10,13-dimethyl-1,2,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-3-one
CAS152-62-5
PubChem CID9051
InChIKeyJGMOKGBVKVMRFX-HQZYFCCVSA-N
logP4.5 (XLogP 3.8)
Polar surface area34.14 Ų
H-bond acceptors / donors2 / 0
Drug-likeness (QED)0.71
Lipinski violations0
SMILESCC(=O)[C@H]1CC[C@H]2[C@@H]3C=CC4=CC(=O)CC[C@@]4(C)[C@@H]3CC[C@]12C

Biology & Pharmacokinetics

Pharmacokinetics predicted

Bioavailability70.0%
Half-life0.572 h
Volume of distribution1.759 L/kg
Protein binding93.0%
BBB penetrantYes

Enzyme interactions

EnzymeRoleDetail
CYP1A2Substrate
CYP2B6Inhibitor
CYP2C19Inhibitor
CYP2C19Substrate
CYP2C8Inhibitor
CYP2C9Substrate
CYP2D6Substrate
CYP3A4Inhibitor
CYP3A4Substrate

Receptor binding (top 1)

TargetActionAffinity
Progesterone receptor (PGR) Agonist pKi 6.9

Transporters

BCRP (Inhibitor)BSEP (Inhibitor)MRP1 (Inhibitor)OATP1B1 (Inhibitor)OATP1B3 (Inhibitor)P-gp (Inhibitor)P-gp (Substrate)

Registered Products (4)

BrandForm / strengthPackAgentCitizen (JOD)
Motaston Tablet 10 mg 20 tab Al-Motakadema Pharmaceutical LTD. 4.380
Femoston Tab Tablet 2 mg, 10 mg 3X28 Khraim Drug Store 17.140
Femoston conti Tablet 1 mg, 5 mg 28 tab Khraim Drug Store 19.050
Duphaston Tab Tablet 10 mg 20 tab Abu Sheikha Drug Store